Milestone Pharmaceuticals Inc

NASDAQ:MIST  
5.88
-0.14 (-2.33%)
Earnings Announcements

Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results And Provides Clinical And Corporate Update

Published: 11/12/2021 12:47 GMT
Milestone Pharmaceuticals Inc (MIST) - Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Corporate Update.
Qtrly Net Loss per Share $0.34.
Q3 Earnings per Share View $-0.38 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.